Invesco Ltd. Cyma Bay Therapeutics, Inc. Transaction History

Invesco Ltd.

  • $460 Billion
  • Q2 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
SELL
$12.63 - $24.47 $2.7 Million - $5.24 Million
-214,102 Reduced 22.73%
727,706 $17.2 Million
Q3 2023

Nov 13, 2023
BUY
$10.86 - $17.62 $214,908 - $348,682
19,789 Added 2.15%
941,808 $14 Million
Q2 2023

Aug 11, 2023
SELL
$7.47 - $10.95 $243,581 - $357,057
-32,608 Reduced 3.42%
922,019 $10.1 Million
Q1 2023

May 12, 2023
BUY
$5.88 - $9.59 $4.8 Million - $7.82 Million
815,494 Added 586.13%
954,627 $8.32 Million
Q4 2022

Feb 13, 2023
SELL
$3.22 - $6.27 $95,186 - $185,347
-29,561 Reduced 17.52%
139,133 $872,000
Q3 2022

Nov 14, 2022
SELL
$2.77 - $4.25 $156,671 - $240,380
-56,560 Reduced 25.11%
168,694 $590,000
Q2 2022

Aug 15, 2022
BUY
$1.72 - $3.39 $4,745 - $9,353
2,759 Added 1.24%
225,254 $664,000
Q1 2022

May 16, 2022
SELL
$2.77 - $3.64 $107,232 - $140,911
-38,712 Reduced 14.82%
222,495 $692,000
Q4 2021

Feb 14, 2022
BUY
$3.23 - $4.6 $8,452 - $12,038
2,617 Added 1.01%
261,207 $883,000
Q3 2021

Nov 15, 2021
BUY
$3.47 - $4.42 $71,072 - $90,530
20,482 Added 8.6%
258,590 $944,000
Q2 2021

Aug 17, 2021
BUY
$3.94 - $4.92 $51,361 - $64,137
13,036 Added 5.79%
238,108 $1.04 Million
Q1 2021

May 17, 2021
BUY
$4.23 - $6.55 $36,652 - $56,755
8,665 Added 4.0%
225,072 $1.02 Million
Q4 2020

Feb 16, 2021
SELL
$5.73 - $9.03 $9.52 Million - $15 Million
-1,661,179 Reduced 88.47%
216,407 $1.24 Million
Q3 2020

Nov 16, 2020
BUY
$3.32 - $7.24 $5.92 Million - $12.9 Million
1,781,858 Added 1861.38%
1,877,586 $13.6 Million
Q2 2020

Aug 14, 2020
SELL
$1.41 - $4.25 $13,939 - $42,015
-9,886 Reduced 9.36%
95,728 $334,000
Q1 2020

May 15, 2020
BUY
$1.25 - $2.02 $132,017 - $213,340
105,614 New
105,614 $156,000
Q4 2019

Feb 14, 2020
SELL
$1.33 - $5.93 $257,454 - $1.15 Million
-193,575 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$5.12 - $7.21 $196,423 - $276,604
38,364 Added 24.72%
193,575 $991,000
Q2 2019

Aug 14, 2019
BUY
$6.05 - $13.66 $939,026 - $2.12 Million
155,211 New
155,211 $1.11 Million

Others Institutions Holding CBAY

# of Institutions
7
Shares Held
1.82M
Call Options Held
0
Put Options Held
0
View Full List

About CymaBay Therapeutics, Inc.

CBAY Quotes by TradingView
  • Ticker CBAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,677,904
  • Description
  • CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...
More about CBAY
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email